Companies: 10,795·Total market cap: $144.5T
Eastgate Biotech Corp.

Eastgate Biotech Corp.

ETBIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6172650
P/E Ratio—
52W High$0.004
52W Low$0.0001
SEC Filings

Eastgate Biotech Corp. (ETBI) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001099574 · ETBI · OTC · as of Jun 10, 2026

Filing snapshot

148
Total Filings
8-K
Latest Form
2019-09-16
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001099574 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2018-03-01
Fiscal Year End
Mar 1, 2018
Accession No.
0001640334-18-000403
Primary Document
etbi_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001099574 · Accession 0001640334-18-000403

Latest Key Filings

10-QQuarterly Report
CONVERTED BY EDGARWIZ
2019-03-04
View 10-Q on SEC
8-KCurrent Report
8K EASTGATE BIOTECH - 09.04.19
2019-09-16Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8K EASTGATE BIOTECH - 09.04.19
2019-09-16
View
15-12G15-12G
FORM 15
2019-08-02
View
10-QQuarterly Report
CONVERTED BY EDGARWIZ
2019-03-04
View
10-QQuarterly Report
EASTGAT BIOTECH - 10Q -JUNE 30, 2017 - Q2
2018-12-18
View
10-Q/AQuarterly Report (Amended)
FORM 10Q/A - 03/31/17 - EASTLAND BIOTECHNOLOGY CORP.
2018-08-17
View
10-QQuarterly Report
FORM 10Q - 03/31/17 - EASTLAND BIOTECHNOLOGY CORP.
2018-08-17
View
8-KCurrent Report
8K - EASTGATE - CHANGE IN AUDITOR - 06.01.18
2018-06-08
View
8-KCurrent Report
8-K EASTGATE MAY 4, 2018
2018-05-07
View
10-Q/AQuarterly Report (Amended)
FORM 10-Q/A
2018-03-01
View
10-Q/AQuarterly Report (Amended)
FORM 10-Q
2018-03-01
View
10-Q/AQuarterly Report (Amended)
FORM 10-Q/A
2018-03-01
View
10-KAnnual Report
FORM 10-K
2018-03-01
View
8-K/ACurrent Report (Amended)
FORM 8-K/A
2017-05-25
View
8-KCurrent Report
FORM 8-K
2017-05-22
View
8-KCurrent Report
FORM 8-K
2017-05-16
View
Showing 1–15 of 130 filingsForm 4 / 144 hidden· 148 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001099574  |  Exchange: OTC · Healthcare

Eastgate Biotech Corp. (OTC: ETBI) has submitted 148 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001099574, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Eastgate Biotech Corp.'s most comprehensive regulatory disclosure. The most recent Eastgate Biotech Corp. 10-K was filed on 2018-03-01 for fiscal year ending 2018. Historical ETBI 10-K annual reports are available from 1999 through 2018.

Investors researching Eastgate Biotech Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
GPFT SEC Filings →CBDL SEC Filings →FORZ SEC Filings →BSYI SEC Filings →QRON SEC Filings →EMED SEC Filings →LRSV SEC Filings →DRWN SEC Filings →
→ ETBI Financials→ ETBI Earnings→ ETBI Insider Trades

Frequently Asked Questions

ETBI SEC Filings · 8 questions

Eastgate Biotech Corp. (ETBI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 148 filings and access original documents at no cost. Eastgate Biotech Corp.'s CIK is 0001099574.

ETBI SEC filingsEastgate Biotech Corp. SEC documentsfind ETBI 10-K